Tenet Healthcare Corp. 10-K Summary (Fiscal Year Ended May 31, 1995)
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended May 31, 1995, for Tenet Healthcare Corporation (formerly National Medical Enterprises, Inc.). Tenet is a leading investor-owned healthcare company operating general hospitals and related facilities primarily in urban areas across 13 U.S. states. The reporting period was defined by a major strategic shift: the acquisition of American Medical Holdings, Inc. ("AMH") on March 1, 1995, which doubled the company's hospital count from 35 to 70 domestic facilities. Concurrently, Tenet initiated a divestiture of its international operations and its former psychiatric division to focus on core domestic general hospital services.
Key Financial Metrics
Revenue and Profit: The filing incorporates financial statements by reference; however, Exhibit 11 provides specific earnings data. Income from continuing operations for fiscal 1995 was $194.4 million, representing a decrease from $215.9 million in fiscal 1994. Primary earnings per share (EPS) from continuing operations were $1.10, down from $1.29 in the prior year. Fully diluted EPS was $1.06.
Operational Scale: At May 31, 1995, Tenet operated 70 domestic general hospitals with 15,451 licensed beds. Average occupancy was 47%, consistent with the prior year. International operations contributed approximately 5% of consolidated net operating revenues.
Debt and Liquidity: The company has significant debt instruments registered, including 9 5/8% Senior Notes due 2002 and 10 1/8% Senior Subordinated Notes due 2005. As of May 31, 1995, Tenet held approximately $104 million in outstanding loans secured by real property and $51 million in capitalized lease obligations. The aggregate market value of common stock held by non-affiliates was approximately $3.04 billion as of July 31, 1995.
Cash Flow and Margins: Specific cash flow figures and operating margins are not explicitly detailed in the provided text, as the Management's Discussion and Analysis (MD&A) and full financial statements are incorporated by reference to the Annual Report to Shareholders.
Material Changes Versus Prior Period
- Acquisition of AMH: The most significant change was the March 1, 1995, merger with AMH, increasing the hospital portfolio from 35 to 70 facilities and beds from 6,873 to 15,451.
- Divestiture of International Assets: Tenet sold its two Singapore hospitals in June 1995 and entered agreements to sell its 52% interest in Australian Medical Enterprises (AME) and other international interests to refocus on domestic operations.
- Discontinued Operations: The company sold or closed all but two of its 54 freestanding psychiatric hospitals and sold its Management Services Division, effectively exiting the psychiatric and substance abuse recovery business.
- Legal Settlements: The company resolved federal investigations regarding improper practices in its former psychiatric division, agreeing to pay $362.7 million to the federal government and $16.3 million to 27 states. Additionally, a global settlement of shareholder derivative and class action suits was reached, requiring a payment of $31.25 million by the company (plus interest).
Guidance, Outlook, Risks, and Contingencies
Outlook and Strategy: Management intends to focus exclusively on domestic general hospitals. Future growth is expected through acquisitions (e.g., pending transactions in New Orleans and El Paso) and the development of outpatient and sub-acute care services to address industry shifts away from inpatient care.
Risks and Contingencies:
- Regulatory and Reimbursement: The company faces significant pressure from Medicare and Medicaid reimbursement rates, which are often below retail costs. Legislative changes (e.g., OBRA '93) have reduced payment rates, and future reductions are anticipated.
- Legal Exposure: Despite settlements, Tenet faces ongoing litigation related to its former psychiatric operations, including class actions alleging fraud and conspiracy. The company expects to incur substantial legal expenses and anticipates additional lawsuits.
- Compliance: Tenet is subject to a corporate compliance program mandated by its settlement with federal agencies, requiring strict oversight and reporting of potential violations.
- Competitive Landscape: The industry is characterized by high competition, managed care pressures, and significant unused capacity, leading to downward pressure on prices and occupancy.
Investor Verification Checklist
- Financial Statements: Verify the full consolidated balance sheet, income statement, and cash flow statement in the 1995 Annual Report to Shareholders, as specific totals for revenue, total debt, and cash flow are not in this text.
- Legal Settlement Costs: Confirm the total cash impact of the $362.7 million federal settlement and the $31.25 million shareholder settlement on the company's liquidity and reserves.
- AMH Integration: Review the MD&A for details on the integration costs and synergies realized from the AMH merger, which significantly altered the company's asset base mid-year.
- Divestiture Proceeds: Verify the closing status and financial proceeds from the sale of international assets (Singapore, Australia, Thailand, Malaysia) and the Hillhaven investment.
- Reimbursement Trends: Analyze the specific impact of Medicare PPS and Medicaid rate changes on the 47% occupancy rate and future revenue projections.